Paper Details

  1. Home
  2. Paper Details

Comparative efficacy and acceptability of antidepressants in Parkinson's disease: a network meta-analysis.

Author: DongJiangchuan, LiuJinling, SuYing, SunShenggang, WangLei, YanPeng

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.

Overview

Depression is a common problem for people with Parkinson's disease (PD). While various antidepressants are used, including tricyclic antidepressants (TCAs), selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), and dopamine agonists, research hasn't consistently shown which type is best as a first-line treatment for depression in PD.
Paper Details　
Original Abstract of the Article :
Depression is a common non-motor symptom in patients with Parkinson's disease (PD). There are many kinds of antidepressants being used, such as tricyclic antidepressants (TCAs), selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), and Dopamine ag...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3788746/

データ提供：米国国立医学図書館（NLM）

Choosing the Right Antidepressant for Parkinson's Disease: A Network Meta-Analysis

Navigating the [Parkinson's disease] desert can be a challenging journey, and one of the most common obstacles is [Depression]. This study explores the vast landscape of [Antidepressants] to help clinicians choose the best treatment option for individuals with [Parkinson's disease] and [Depression].

Comparing Antidepressants in Parkinson's Disease

The study provides a comprehensive analysis of the effectiveness and acceptability of different classes of [Antidepressants] for treating [Depression] in patients with [Parkinson's disease]. The researchers used a network meta-analysis to compare the efficacy of [Tricyclic antidepressants (TCAs)], [Selective serotonin reuptake inhibitors (SSRIs)], [Serotonin and norepinephrine reuptake inhibitors (SNRIs)], and [Dopamine agonists] in this unique population.

Navigating the Choices for Antidepressant Treatment

This study offers valuable insights for clinicians treating patients with [Parkinson's disease] and [Depression]. By understanding the relative effectiveness and acceptability of different [Antidepressants], healthcare professionals can make more informed decisions about treatment options for these patients, taking into account individual needs and preferences.

Dr.Camel's Conclusion

The treatment of [Depression] in individuals with [Parkinson's disease] is a complex process. This study provides a valuable tool for clinicians to make informed decisions about [Antidepressant] treatment, considering the specific needs and characteristics of each patient. Further research is needed to better understand the long-term effectiveness and safety of different [Antidepressants] in this population.

Date :
  1. Date Completed 2014-04-29
  2. Date Revised 2022-12-07
Further Info :

Pubmed ID

24098546

DOI: Digital Object Identifier

PMC3788746

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.